Repository of Research and Investigative Information

Repository of Research and Investigative Information

Baqiyatallah University of Medical Sciences

Cutaneous manifestations related to the COVID-19 pandemic: a review article

(2021) Cutaneous manifestations related to the COVID-19 pandemic: a review article. Cutaneous and Ocular Toxicology. pp. 168-174. ISSN 1556-9527

Full text not available from this repository.

Official URL: http://apps.webofknowledge.com/InboundService.do?F...

Abstract

Background Skin lesions are either caused by COVID-19 disease or they can be due to other driving forces related to the COVID-19 pandemic. Aim Considering the fact that the reported data in different articles for the type and prevalence of skin manifestations related to the COVID-19 pandemic are inconsistent, we have described the mechanism and type of skin lesions related to the COVID-19 pandemic. Methods In this review article, we have searched the Medline database (PubMed) for the combination of the following key terms "Dermatological Manifestation", "cutaneous Manifestation", "Skin Manifestation", "COVID-19", "SARS-CoV-2". Results The prevalence of skin manifestations related to COVID-19 ranged from 0.2 to 20. The majority of these skin lesions are maculopapular eruptions. The skin presentations related to the COVID-19 pandemic are described below. Traumatic skin conditions such as dermatitis in individuals, especially those with allergies, might initiate secondary to over-washing or rinsing with inappropriate detergents. Also, inappropriate use of personal protective equipment (mask-gloves-shield) can trigger skin lesions on the face and hands or aggravate the lesions of acne, seborrhoeic dermatitis, eczema, etc. Furthermore, cutaneous adverse drug reactions may occur during hospitalization or outpatient treatment of COVID-19 patients. Also, psychocutaneous disorders due to acute stress can trigger or deteriorate several skin manifestations. Moreover, COVID-19 prevalence and course may be changed in patients with autoimmune or chronic inflammatory underlying skin disorders such as psoriasis, lupus erythematosus, pemphigus, scleroderma who are on immunosuppressive or biological medications to control their disorders. Conclusion Due to the various dimensions of skin organ involvement and the large population affected, long-term skin conditions following this pandemic can be a lot more problematic than it appears. Serious preventive measures and medical supports are necessary to avoid skin disorders from becoming permanent or even chronic.

Item Type: Article
Keywords: COVID-19 skin manifestation maculopapular rash cutaneous drug reactions traumatic skin condition psychocutaneous disorders autoimmune skin disorders inflammatory skin disorders Ophthalmology Toxicology
Page Range: pp. 168-174
Journal or Publication Title: Cutaneous and Ocular Toxicology
Journal Index: ISI
Volume: 40
Number: 2
Identification Number: https://doi.org/10.1080/15569527.2021.1919138
ISSN: 1556-9527
Depositing User: مهندس مهدی شریفی
URI: http://eprints.bmsu.ac.ir/id/eprint/9510

Actions (login required)

View Item View Item